Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Aranesp darbepoetin alfa hematology data

Additional data from the open-label DAHANCA 10 trial in 515 patients showed

Read the full 121 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE